International Journal of Radiation Oncology * Biology * Physics
Volume 71, Issue 2 , Pages 358-361, 1 June 2008

Use of Local 111In-Capromab Pendetide Scan Results to Predict Outcome After Salvage Radiotherapy for Prostate Cancer

  • Bridget F. Koontz, M.D.

      Affiliations

    • Department of Radiation Oncology, Duke University Medical Center, Durham, NC
    • Duke Prostate Center, Duke University Medical Center, Durham, NC
    • Corresponding Author InformationReprint requests to: Bridget F. Koontz, M.D., Department of Radiation Oncology, Duke University Medical Center, Box 3085, Durham, NC 27710. Tel: (919) 668-7342; Fax: (919) 668-7345
    • ,
  • Vladimir Mouraviev, M.D., Ph.D.

      Affiliations

    • Duke Prostate Center, Duke University Medical Center, Durham, NC
    • Department of Surgery, Division of Urologic Surgery, Duke University Medical Center, Durham, NC
    • ,
  • Jeffrey L. Johnson, M.S.

      Affiliations

    • Duke Cancer Center Biostatistics, Duke University Medical Center, Durham, NC
    • ,
  • Janice Mayes, B.S.

      Affiliations

    • Department of Surgery, Division of Urologic Surgery, Duke University Medical Center, Durham, NC
    • ,
  • Stephanie H. Chen, B.S.

      Affiliations

    • Department of Surgery, Division of Urologic Surgery, Duke University Medical Center, Durham, NC
    • ,
  • Terence Z. Wong, M.D., Ph.D.

      Affiliations

    • Department of Radiology, Duke University Medical Center, Durham, NC
    • ,
  • Mitchell S. Anscher, M.D.

      Affiliations

    • Department of Radiation Oncology, Virginia Commonwealth University School of Medicine, Richmond, VA
    • ,
  • Leon Sun, M.D., Ph.D.

      Affiliations

    • Duke Prostate Center, Duke University Medical Center, Durham, NC
    • Department of Surgery, Division of Urologic Surgery, Duke University Medical Center, Durham, NC
    • ,
  • Judd Moul, M.D.

      Affiliations

    • Duke Prostate Center, Duke University Medical Center, Durham, NC
    • Department of Surgery, Division of Urologic Surgery, Duke University Medical Center, Durham, NC
    • ,
  • Thomas J. Polascik, M.D.

      Affiliations

    • Duke Prostate Center, Duke University Medical Center, Durham, NC
    • Department of Surgery, Division of Urologic Surgery, Duke University Medical Center, Durham, NC

Received 22 August 2007; received in revised form 4 October 2007; accepted 6 October 2007. published online 03 January 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Presented in part at the 2007 American Society of Clinical Oncology Prostate Symposium, February 22–24, 2007, Orlando, FL.

 Conflict of interest: T.J. Polascik is a funded investigator for Cytogen Corp. J.Moul is a paid lecturer and consultant for Cytogen.

PII: S0360-3016(07)04443-4

doi:10.1016/j.ijrobp.2007.10.020

International Journal of Radiation Oncology * Biology * Physics
Volume 71, Issue 2 , Pages 358-361, 1 June 2008

Article Tools

* Image Usage & Resolution